Skip to main content
S

SCL Science Inc. — Investor Relations & Filings

Ticker · 246960 ISIN · KR7246960009 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2025-03-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 246960

About SCL Science Inc.

https://sclscience.com/en

SCL Science Inc., formerly InnoTherapy Inc., is a healthcare company focused on digital innovation and advanced medical technologies. The company develops and commercializes medical hemostatic agents based on its proprietary biomimetic technology, including the Bio-inspired Medical Materials (BiMM) product line. Leveraging 40 years of expertise in medical science, SCL Science is also dedicated to building a digital healthcare ecosystem using artificial intelligence and high-quality medical data. Its services extend to clinical trial analysis, bio-logistics, and an expanding drug discovery platform focused on AI-driven cancer vaccine development. The company serves hospitals, research laboratories, and other medical institutions.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by SCL Science. It outlines the date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and details regarding the board's resolution. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and the items to be voted upon, which fits the definition of a Proxy Solicitation & Information Statement.
2025-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for SCL Science. It contains the agenda for the meeting, including the approval of financial statements, election of directors, and remuneration limits. It also includes detailed management information, such as board activity, major shareholder transactions, and business overviews, which are standard components of proxy materials provided to shareholders for an upcoming AGM. Therefore, it is classified as Proxy Solicitation & Information Statement.
2025-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (Proxy Solicitation & Information Statement) used to request shareholder votes for an upcoming General Meeting. It includes details on the meeting date, agenda items (such as approval of financial statements and director appointments), and instructions for electronic voting. While it contains financial statements, these are provided as reference material for the shareholders' vote, not as a standalone Annual Report or Earnings Release.
2025-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from SCL Science regarding a significant change (over 30%) in revenue or profit structure, which is a standard disclosure requirement for publicly traded companies in Korea. It provides a summary table of financial performance (revenue, operating profit, net income) comparing the current fiscal year to the previous one. Since this is a specific regulatory disclosure of financial results rather than a full annual report or a simple announcement of a report's availability, it falls under the 'Regulatory Filings' category as a general corporate disclosure. FY 2024
2025-02-14 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and explicitly lists the outcome of a shareholder vote regarding a stock exchange proposal. This falls under the category of official results from shareholder votes at a general meeting.
2025-02-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details changes in share ownership by a major shareholder (Kim Kyung Su and related parties) in the company 'SCL Science'. This type of filing is specifically designed to notify the market when an entity crosses a significant ownership threshold (typically 5%), which corresponds to the 'Major Shareholding Notification' category.
2025-02-03 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.